Assignee
BCN PEPTIDES SA
ES·3 granted patents·3 pending applications·2 citations·filing 2009–2020
Top patents by PatentIndex Score
6 records- 0166US11571407B2Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosisBCN PEPTIDES SA·Filed 2014·Granted Feb 7, 2023·2 cites·20 claims
- 0255US2011206752A1Compositions for the treatment of pain and/or inflamationBCN PEPTIDES SA·Filed 2009·Application pending·0 cites
- 0346US2019184054A1Compositions for the treatment of pain and/or inflammationBCN PEPTIDES SA·Filed 2018·Application pending·0 cites
- 0444US12297294B2Cortistatin analogues for the treatment of inflammatory and/or immune diseasesBCN PEPTIDES SA·Filed 2014·Granted May 13, 2025·0 cites·7 claims
- 0537US2013172529A1Method for synthesizing thymosinsBCN PEPTIDES SA·Filed 2012·Application pending·0 cites
- 0636US12544431B2Peptides for the treatment of cancer and/or metastasisBCN PEPTIDES SA·Filed 2020·Granted Feb 10, 2026·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when BCN PEPTIDES SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →